- Search results for 871026-44-7
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
3 products were found matching "871026-44-7"!
Close filters
Filter by:
No results were found for the filter!
Item number: SYN-1153-M001
Soluble in DMSO or ethanol. TAK-285 is a novel investigational dual HER2/EGFR inhibitor with IC(50) values of 17 and 23nM, respectively. Target: EGFR - HER2 , Kinase Group: RTK , Substrate: Tyrosine
| Keywords: | TAK285 |
| Application: | EGFR / HER2 inhibitor |
| CAS | 871026-44-7 |
| MW: | 548 D |
From 254.00€
*
Item number: Cay29157-1
TAK-285 is a dual inhibitor of EGFR and HER2 (IC50s = 23 and 17 nM, respectively). It is selective for EGFR and HER2 over a panel of 36 kinases (IC50s = 250->10,000 nM). TAK-285 inhibits the proliferation of BT474 breast cancer cells (GI50 = 17 nM) as well as induces tumor regression in a 4-1st gastric...
| Keywords: | N-[2-[4-[[3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl]amino]-5H-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methyl-b... |
| Application: | EGFR / HER2 dual inhibitor |
| CAS | 871026-44-7 |
| MW: | 548 D |
From 44.00€
*
Item number: TGM-T6039-100mg
Description: TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM, >10-fold selectivity for HER1/2 than HER4, less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc. Phase 1. Target: MEK, EGFR, Aurora Kinase, HER. Smiles:...
| Keywords: | TAK285 , TAK 285 |
| Application: | EGFR / HER2 dual inhibitor |
| CAS | 871026-44-7 |
| MW: | 547.96 D |
From 31.00€
*
